French Peer-Reviewed Study announces Cure for Coronavirus: HCQ + Azithromycin
(1) Long-term use of Chloroqine could affect retina
(2) French Peer-Reviewed Study announces Cure for Coronavirus: HCQ + Azithromycin
(3) Recipe for Bitter melon smoothie
This and previous material have been added to my Coronavirus webpage http://mailstar.net/coronavirus.html
(1) Long-term use of Chloroqine could affect retina
- by Peter Myers, March 22, 2020
I must mention this for legal reasons, given that we live in a Nanny State.
Leo schmit <This email address is being protected from spambots. You need JavaScript enabled to view it.> informs me that one possible side-effect of CQ and HCQ is the 'loosening up' of the retina. This is of relevance for people with eye conditions. This effect is 'rare', but may be associated with long term use (5 years), body weight and poor renal functions (kidney).
However CQ was widely and successfully used as an anti-malarial drug for decades.
Any such effect would depend on dosage and duration; the dosage I took is very low; anyway, beating the virus is my #1 priority at present.
In the peer-reviewed study below (item 2), Coronavirus was cured with HCQ + Azithromycin. No doubt the HCQ was administered every day, but the duration was short, so surely the cure from a deadly disease outweighs the possible side-effects.
This cure is cheap; bad luck for Big Pharma who, no doubt, were hoping to make a killing from the pandemic.
(2) French Peer-Reviewed Study announces Cure for Coronavirus: HCQ + Azithromycin
From: chris lancenet <This email address is being protected from spambots. You need JavaScript enabled to view it.>
French Peer-Reviewed Study: Our Treatment Cured 100% Of Coronavirus Patients
By Hank Berrien
DailyWire.com
{photo} Didier Raoult, Professor at the Faculty of Medicine of Marseille, poses on November 6, 2014 in his office at the Facutly of Medicine in Marseille, southern France.Photo by Anne-Christine Poujoulat/AFP via Getty Images
On Wednesday, Gregory Rigano, an advisor to the Stanford University School of Medicine, claimed that a world-renowned French researcher had tested a promising cure for coronavirus.
He tweeted: "Full peer-reviewed study has been released by Didier Raoult MD, PhD. After 6 days 100% of patients treated with HCQ + Azithromycin were virologically cured."
UPDATE:
Full peer reviewed study has been released by Didier Raoult MD, PhD https://t.co/DzFTv13wYn.
After 6 days 100% of patients treated with HCQ + Azithromycin were virologically cured
p-value <.0001https://t.co/vttAIWbPwJ
— Gregory Rigano (@RiganoESQ) March 18, 2020
Appearing on Fox News Wednesday night, Rigano followed up by stating:
And I’m here to report that as of this morning, about 5:00 this morning, a well-controlled peer-reviewed study carried out by the most eminent infectious disease specialist in the world—Didier Raoult, MD, PhD—out of the south of France, in which he enrolled 40 patients, again, a well-controlled peer review study, that showed a 100 percent cure rate against coronavirus. The study was released this morning on my Twitter account, @Riganoesq as well as our most recent website, @covidtrial.io.
The study was recently accepted to the International Journal of Antimicrobial Agents by Elsevier.
Rigano continued, "In fact to be able to cure a virus was said to be mathematically impossible, and the first company that did it was a small biotech called Pharmacet that was acquired by Gilead Sciences in a cure for hepatitis C. What we’re here to announce is a second cure to a virus of all time." ...
According to covidtrial.io, here are the backgrounds for Didier Raoult and another doctor involved in the study:
Didier Raoult created the Rickettsia Unit at Aix-Marseille University.
Since 2008, Dr. Raoult has served as the director of URMITE (Research Unit in Infectious and Tropical Emergent Diseases), collaborating with CNRS (National Center for the Scientific Research), IRD (Research for the Development Institute), INSERM (National Institute of Health and Medical Research) and Aix Marseille University. His laboratory employs more than 200 people, including nearly 100 active researchers who publish between 250 and 350 papers per year and have produced over 50 patents.
Dr. Chandra Duggirala has a bio that states:
He founded Novobionics, a medical device company to treat diabetes and obesity non-invasively and invented it’s double sleeve technology. He lead the company through preclinical trials and several US and international patents. He is also the Principal Investigator of the Reset-Youth trial, one of the largest clinical trials for investigating the reversibility of epigenetic markers of aging. He also founded a software company at the intersection of nutritional biology and A.I.
(3) Recipe for Bitter melon smoothie
From: chris lancenet <This email address is being protected from spambots. You need JavaScript enabled to view it.>
Maki suggests for a good taste
bitter melon slices 40 g
banana one full
soy milk 150 ml
lemon or lime juice one big spoon
MIXER makes smoothy energy drink
1
